Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.40 | N/A | +0.50% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.40 | N/A | +0.50% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook on their product lines. They noted challenges in the market but emphasized their strategic positioning.
Management highlighted strong performance in key product categories.
They expressed confidence in maintaining market share despite competitive pressures.
The earnings report shows that Prestige Consumer HE exceeded expectations on EPS, which likely contributed to the 2.21% rise in stock price. Investors may be encouraged by management's positive remarks about product performance. However, the lack of revenue data and forward guidance leaves some uncertainty about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Jul 29, 2013